Literature DB >> 28403981

Management of the multiple symptoms of irritable bowel syndrome.

Magnus Simrén1, Hans Törnblom2, Olafur S Palsson3, William E Whitehead3.   

Abstract

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. A stepwise management approach is advocated for patients with IBS. For a substantial proportion of patients with mild symptoms, general management principles, including making a confident diagnosis and offering explanation, reassurance, and dietary and lifestyle advice, are sufficient. However, many patients continue to have moderate-to-severe symptoms and are not satisfied solely with this approach. In these patients, use of pharmacotherapy on the basis of the predominant symptom (constipation, diarrhoea, pain, or bloating) or combination of symptoms is the next step. For patients with symptoms that are refractory to these initial treatment options and those who have comorbid conditions or psychological symptoms, a combination of therapies should be used, and the use of psychotropic drugs and psychological treatment alternatives is often effective. Finally, the key to successful treatment of patients with IBS is a good physician-patient relationship and use of person-centred care principles.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28403981     DOI: 10.1016/S2468-1253(16)30116-9

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  18 in total

1.  Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.

Authors:  Mercedes Amieva-Balmori; Enrique Coss-Adame; Nikilesh S Rao; Brisa M Dávalos-Pantoja; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

2.  Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation.

Authors:  Elodie Picard; Frederic Antonio Carvalho; Francina Agosti; Emmanuel Bourinet; Denis Ardid; Alain Eschalier; Laurence Daulhac; Christophe Mallet
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

3.  Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.

Authors:  A Mack; J S Bobardt; A Haß; K B Nichols; R M Schmid; C K Stein-Thoeringer
Journal:  Gut Microbes       Date:  2019-12-06

4.  Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.

Authors:  Hannah Ceuleers; Nikita Hanning; Jelena Heirbaut; Samuel Van Remoortel; Jurgen Joossens; Pieter Van Der Veken; Sven M Francque; Michelle De Bruyn; Anne-Marie Lambeir; Joris G De Man; Jean-Pierre Timmermans; Koen Augustyns; Ingrid De Meester; Benedicte Y De Winter
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

5.  Management of functional gastrointestinal disorders.

Authors:  Asma Fikree; Peter Byrne
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 6.  Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Authors:  Paul Moayyedi; Fermín Mearin; Fernando Azpiroz; Viola Andresen; Giovanni Barbara; Maura Corsetti; Anton Emmanuel; A Pali S Hungin; Peter Layer; Vincenzo Stanghellini; Peter Whorwell; Frank Zerbib; Jan Tack
Journal:  United European Gastroenterol J       Date:  2017-09-28       Impact factor: 4.623

Review 7.  Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights.

Authors:  Sarah W Kinsinger
Journal:  Psychol Res Behav Manag       Date:  2017-07-19

8.  Neuromuscular electrical stimulation as an adjunctive therapy to drotaverine hydrochloride for treating patients with diarrhea-predominant irritable bowel syndrome: A retrospective study.

Authors:  Jian-Kui Wang; Juan Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 9.  The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.

Authors:  Joost Algera; Esther Colomier; Magnus Simrén
Journal:  Nutrients       Date:  2019-09-09       Impact factor: 5.717

10.  Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients.

Authors:  Shi-Rui Zhao; Xiao-Mei Ni; Xin-An Zhang; Hong Tian
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.